This CTD dossier owner and manufacturer, established in 2000, specializes in developing and manufacturing a wide range of health solutions across the EU, North America, and other regions. With over US$800 million in annual working capital, they operate through three subsidiaries and boast an extensive product portfolio spanning prescription medications, over-the-counter drugs, medical devices, and supplements. They prioritize quality and innovation, investing heavily in research and development. While specific therapy areas and dosage forms aren't mentioned, their commitment to technology suggests a focus on advanced pharmaceutical manufacturing processes and potential GMP certifications. The company also holds product patents, further solidifying their position as a key player in the global healthcare market.